You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 8,057,811

✉ Email this page to a colleague

« Back to Dashboard

Which drugs does patent 8,057,811 protect, and when does it expire?

Patent 8,057,811 protects VERSACLOZ and is included in one NDA.

This patent has six patent family members in six countries.

Summary for Patent: 8,057,811

Patent landscape, scope, and claims:

Title:	Stable clozapine suspension formulation
Abstract:	A physicochemically stable aqueous composition including clozapine suspension.
Inventor(s):	Surman; Peter William (Auckland, NZ), Ferguson; Sharon (Auckland, NZ), Mak; Wai Bik (Auckland, NZ), McLeod; Andrew Douglas (Auckland, NZ)
Assignee:	Douglas Pharmaceuticals Limited (Auckland, NZ)
Application Number:	10/561,930
Patent Claim Types: see list of patent claims
More… ↓ ⤷ Subscribe

Drugs Protected by US Patent 8,057,811

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Tasman Pharma	VERSACLOZ	clozapine	SUSPENSION;ORAL	203479-001	Feb 6, 2013		RX	Yes	Yes	8,057,811	⤷ Subscribe	Y				⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

Foreign Priority and PCT Information for Patent: 8,057,811

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
New Zealand	527142	Jul 23, 2003

PCT Information
PCT Filed	July 22, 2004	PCT Application Number:	PCT/NZ2004/000158
PCT Publication Date:	January 27, 2005	PCT Publication Number:	WO2005/007168

International Family Members for US Patent 8,057,811

Subscribe to access the full database, or Subscribe
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	2004257556	⤷ Subscribe
Canada	2532648	⤷ Subscribe
European Patent Office	1646393	⤷ Subscribe
Spain	2436213	⤷ Subscribe
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.